Neuro Workshop II:
Tracks
Plenary Room
| Tuesday, November 5, 2019 |
| 12:05 PM - 1:35 PM |
| Muses North (Plenary Room) |
Overview
New Horizons in the Diagnosis, Clinical Care Pathway and Research of the SCI Spasticity Syndrome
Speaker
Dr Julian Taylor
Sensorimotor Function Group Lead
Sescam & University of Oxford
New Horizons in the Diagnosis, Clinical Care Pathway and Research of the SCI Spasticity Syndrome: a focus on disabling symptom management to improve residual neuromuscular function and quality of life
Abstract
1. Title: New Horizons in the Diagnosis, Clinical Care Pathway and Research of the SCI Spasticity Syndrome: a focus on disabling symptom management to improve residual neuromuscular function and quality of life.
2. Speakers:
Dr. Fin Biering-Sørensen MD, DMSc. University of Copenhagen, Denmark.
Dr. Peter New MBBS, M Clin Epi, PhD, FAFRM (RACP), Caulfield Hospital and Monash University, Australia.
Dr. Julian Taylor Ph.D, Hospital Nacional de Parapléjicos and University of Oxford (Chairperson).
3. Learning Objectives:
• Understand the clinical presentation and impact of the spinal cord injury spasticity syndrome, including standard diagnosis using the International Spinal Cord Injury Musculoskeletal Basic Data Set and Modified Ashworth Scale, including the impact of symptoms.
• Comprehend the clinical care pathway for optimizing the management of spasticity in people with spinal cord damage according to the international Ability Network.
• Appreciate the importance of measuring cutaneous hyperreflexia in relation to characterising the SCI spasticity syndrome, its impact on lower limb neuromuscular function and modulation using physical techniques (TENS and vibration), activity-based rehabilitation (ergometer) and non-invasive spinal neuromodulation.
4. Material: appropriate for participants at any level.
5. Target audience: Physicians, nurses, physios, occupational therapists, researchers.
6. No prior learning, experience or qualifications are required for the workshop.
7. Outline of the workshop – please list what each speaker will present and the time allocated to each speaker.
Each speaker will speak for 25 minutes with 5 minutes for questions. Open and semi-structured questions will be included to gauge awareness of the topic and to consolidate new information.
Dr. Fin Biering-Sørensen: An update on the assessment of spasticity after spinal cord injury and management of high impact symptoms. The first speaker will provide the latest update of the ISCOS musculoskeletal basic data set, diagnostic tools, impact of SCI spasticity symptoms and future treatment perspectives.
Dr. Peter New: Optimizing the management of spasticity in people with spinal cord damage: a clinical care pathway for treatment decision-making from the Ability Network, an international initiative. The second speaker will give an overview of spasticity management in people with spinal cord damage can be complex and challenging, and will cover evidence-based spasticity management within the context of a clinical care pathway developed by the Ability Network.
Dr. Julian Taylor: Spinal hyperreflexia as a research tool to assess the impact of SCI spasticity syndrome and as a benchmark for therapeutic effects of activity-based neurorehabilitation and neuromodulation. Hyperreflexia will be described as a translational metric to characterize spasticity in people during the subacute SCI rehabilitation phase, and how cutaneous hyperreflexia can be used to benchmark the modulatory effect of physical intervention, activity-based rehabilitation and non-invasive neuromodulation.
8. Equipment: No demonstration of assistive technology or equipment will be made.
9. Conflict of Interest: The speakers of this workshop will provide disclosure information about potential conflicts of interest in the first slide of the presentation and will avoid any commercialization, promotion or advertising of products or materials.
2. Speakers:
Dr. Fin Biering-Sørensen MD, DMSc. University of Copenhagen, Denmark.
Dr. Peter New MBBS, M Clin Epi, PhD, FAFRM (RACP), Caulfield Hospital and Monash University, Australia.
Dr. Julian Taylor Ph.D, Hospital Nacional de Parapléjicos and University of Oxford (Chairperson).
3. Learning Objectives:
• Understand the clinical presentation and impact of the spinal cord injury spasticity syndrome, including standard diagnosis using the International Spinal Cord Injury Musculoskeletal Basic Data Set and Modified Ashworth Scale, including the impact of symptoms.
• Comprehend the clinical care pathway for optimizing the management of spasticity in people with spinal cord damage according to the international Ability Network.
• Appreciate the importance of measuring cutaneous hyperreflexia in relation to characterising the SCI spasticity syndrome, its impact on lower limb neuromuscular function and modulation using physical techniques (TENS and vibration), activity-based rehabilitation (ergometer) and non-invasive spinal neuromodulation.
4. Material: appropriate for participants at any level.
5. Target audience: Physicians, nurses, physios, occupational therapists, researchers.
6. No prior learning, experience or qualifications are required for the workshop.
7. Outline of the workshop – please list what each speaker will present and the time allocated to each speaker.
Each speaker will speak for 25 minutes with 5 minutes for questions. Open and semi-structured questions will be included to gauge awareness of the topic and to consolidate new information.
Dr. Fin Biering-Sørensen: An update on the assessment of spasticity after spinal cord injury and management of high impact symptoms. The first speaker will provide the latest update of the ISCOS musculoskeletal basic data set, diagnostic tools, impact of SCI spasticity symptoms and future treatment perspectives.
Dr. Peter New: Optimizing the management of spasticity in people with spinal cord damage: a clinical care pathway for treatment decision-making from the Ability Network, an international initiative. The second speaker will give an overview of spasticity management in people with spinal cord damage can be complex and challenging, and will cover evidence-based spasticity management within the context of a clinical care pathway developed by the Ability Network.
Dr. Julian Taylor: Spinal hyperreflexia as a research tool to assess the impact of SCI spasticity syndrome and as a benchmark for therapeutic effects of activity-based neurorehabilitation and neuromodulation. Hyperreflexia will be described as a translational metric to characterize spasticity in people during the subacute SCI rehabilitation phase, and how cutaneous hyperreflexia can be used to benchmark the modulatory effect of physical intervention, activity-based rehabilitation and non-invasive neuromodulation.
8. Equipment: No demonstration of assistive technology or equipment will be made.
9. Conflict of Interest: The speakers of this workshop will provide disclosure information about potential conflicts of interest in the first slide of the presentation and will avoid any commercialization, promotion or advertising of products or materials.
Biography
Graduated in Physiology from the University of Sheffield (1986) with a PhD in Neurophysiology and Neuropharmacology from the University of Nottingham (1990). Julian directs clinical research focused on sensorimotor mechanisms of spinal cord injury, including spasticity and neuropathic pain, and more recently mechanisms of activity-based rehabilitation. He is member of the Society for Neuroscience (1990), International Association for the Study of Pain (2001) and founding member of the Castilla La Mancha Pain Society (2010). Recent ongoing clinical projects at the Hospital Nacional de Parapléjicos in Toledo and the National Spinal Injuries Centre in Stoke Mandeville include non-interventional clinical trials related to the study of spinal cord injury disorders using neurophysiological and neuromodulatory techniques. Julian has published more than 80 research articles, with more than 800 citations and a H factor of 20.
